Please enable JavaScript to continue using this application.

Compare $RNTX vs $TENX | Chartloom

Compare

$RNTX vs $TENX

Rein Therapeutics Inc · Tenax Therapeutics Inc

RNTX

Rein Therapeutics Inc

TENX

Tenax Therapeutics Inc

Compare $RNTX vs $TENX

Comparing Rein Therapeutics Inc and Tenax Therapeutics Inc

RNTXRein Therapeutics Inc

TENXTenax Therapeutics Inc

RNTXRein Therapeutics Inc

Market cap

$68M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.5%

52W performance

-42.9%

FCF yield

-27.7%

TENXTenax Therapeutics Inc

Market cap

$50M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-82.9%

YTD performance

-83.1%

52W performance

-76.1%

FCF yield

-92.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RNTX

TENX

Detailed metrics comparison

RNTX

Rein Therapeutics Inc

TENX

Tenax Therapeutics Inc

Market Cap

RNTX$68M

TENX$50M

Enterprise Value

RNTX$59M

TENX$-68M

Price

RNTX$0.79

TENX$1.87

P/E Ratio

RNTXN/A

TENXN/A

P/S Ratio

RNTX0.00x

TENX1,503.03x

EV/Sales

RNTX0.00x

TENX-889.99x

EV/EBITDA

RNTX0.00x

TENX0.00x

P/B Ratio

RNTX1.25x

TENX0.65x

P/FCF Ratio

RNTXN/A

TENXN/A

EV/FCF

RNTX-3.15x

TENX1.49x

PEG Ratio

RNTXN/A

TENXN/A

Forward P/E (NTM)

RNTXN/A

TENXN/A

Forward P/S (NTM)

RNTXN/A

TENXN/A

Revenue (TTM)

RNTX$0

TENX$0

Revenue Growth (YoY)

RNTXN/A

TENX-82.9%

Forward Rev Growth

RNTX113.7%

TENX111.9%

Gross Margin (TTM)

RNTX0.0%

TENX100.0%

Operating Margin (TTM)

RNTX0.0%

TENX0.0%

EBITDA Margin (TTM)

RNTX0.0%

TENX0.0%

Net Margin (TTM)

RNTX0.0%

TENX0.0%

FCF Margin (TTM)

RNTXN/A

TENXN/A

Net Income (TTM)

RNTX$-50M

TENX$-65M

FCF (TTM)

RNTX$-19M

TENX$-46M

EPS (TTM)

RNTX-$0.74

TENX-$1.28

ROE (TTM)

RNTX-15323.0%

TENX-6155.0%

ROA (TTM)

RNTX-11700.0%

TENX-5742.0%

ROIC (TTM)

RNTX-14763.0%

TENX-6155.0%

Cash

RNTX$9M

TENX$118M

Debt

RNTX$0

TENX$0

Net Cash/Debt

RNTX$9M

TENX$118M

Current Ratio (TTM)

RNTX4.27x

TENX15.07x

Quick Ratio (TTM)

RNTX4.26x

TENX14.65x

Debt/Equity (TTM)

RNTX0.00x

TENX0.00x

Debt/Assets (TTM)

RNTX0.0%

TENX0.0%

Interest Coverage (TTM)

RNTXN/A

TENXN/A

Net Debt/EBITDA (TTM)

RNTX0.00x

TENX0.00x

Beta

RNTX1.40

TENX1.00

52W Performance

RNTX-42.9%

TENX-76.1%

YTD Performance

RNTX-36.5%

TENX-83.1%

% from 52W High

RNTX-63.6%

TENX-90.4%

% from 52W Low

RNTX14.4%

TENX42.7%

Asset Turnover (TTM)

RNTX0.00x

TENX0.00x

FCF Yield (TTM)

RNTX-27.7%

TENX-92.8%

Earnings Yield (TTM)

RNTX-73.3%

TENX-130.7%

Dividend Yield (TTM)

RNTXN/A

TENXN/A

Rule of 40

RNTX0.0

TENX-82.9

EV/GP/RG

RNTXN/A

TENXN/A

Ticker research

View RNTX research View TENX research

Metric	RNTX Rein Therapeutics Inc	TENX Tenax Therapeutics Inc
Market & Valuation
Market Cap	$68M	$50M
Enterprise Value	$59M	$-68M
Price	$0.79	$1.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,503.03x
EV/Sales	0.00x	-889.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.25x	0.65x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.15x	1.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-82.9%
Forward Rev Growth	113.7%	111.9%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-50M	$-65M
FCF (TTM)	$-19M	$-46M
EPS (TTM)	-$0.74	-$1.28
ROE (TTM)	-15323.0%	-6155.0%
ROA (TTM)	-11700.0%	-5742.0%
ROIC (TTM)	-14763.0%	-6155.0%
Financial Health
Cash	$9M	$118M
Debt	$0	$0
Net Cash/Debt	$9M	$118M
Current Ratio (TTM)	4.27x	15.07x
Quick Ratio (TTM)	4.26x	14.65x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	1.00
52W Performance	-42.9%	-76.1%
YTD Performance	-36.5%	-83.1%
% from 52W High	-63.6%	-90.4%
% from 52W Low	14.4%	42.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-27.7%	-92.8%
Earnings Yield (TTM)	-73.3%	-130.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-82.9
EV/GP/RG	N/A	N/A
Ticker research	View RNTX research	View TENX research

Valuation

P/S Ratio

RNTX

0.00x

TENX

1,503.03x

EV/FCF

RNTX

-3.15x

TENX

1.49x

Growth & revenue

Revenue Growth TTM

TENX

-82.9%

Forward Revenue Growth

RNTX

113.7%

TENX

111.9%

Profitability & performance

Gross Margin

TENX

100.0%

RNTX

0.0%

ROE

TENX

-6155.0%

RNTX

-15323.0%

FCF Yield %

RNTX

-27.7%

TENX

-92.8%

52-Week Performance

RNTX

-42.9%

TENX

-76.1%

Detailed metrics comparison

RNTX

Rein Therapeutics Inc

TENX

Tenax Therapeutics Inc

Market Cap

RNTX$68M

TENX$50M

Enterprise Value

RNTX$59M

TENX$-68M

Price

RNTX$0.79

TENX$1.87

P/E Ratio

RNTXN/A

TENXN/A

P/S Ratio

RNTX0.00x

TENX1,503.03x

EV/Sales

RNTX0.00x

TENX-889.99x

EV/EBITDA

RNTX0.00x

TENX0.00x

P/B Ratio

RNTX1.25x

TENX0.65x

P/FCF Ratio

RNTXN/A

TENXN/A

EV/FCF

RNTX-3.15x

TENX1.49x

PEG Ratio

RNTXN/A

TENXN/A

Forward P/E (NTM)

RNTXN/A

TENXN/A

Forward P/S (NTM)

RNTXN/A

TENXN/A

Revenue (TTM)

RNTX$0

TENX$0

Revenue Growth (YoY)

RNTXN/A

TENX-82.9%

Forward Rev Growth

RNTX113.7%

TENX111.9%

Gross Margin (TTM)

RNTX0.0%

TENX100.0%

Operating Margin (TTM)

RNTX0.0%

TENX0.0%

EBITDA Margin (TTM)

RNTX0.0%

TENX0.0%

Net Margin (TTM)

RNTX0.0%

TENX0.0%

FCF Margin (TTM)

RNTXN/A

TENXN/A

Net Income (TTM)

RNTX$-50M

TENX$-65M

FCF (TTM)

RNTX$-19M

TENX$-46M

EPS (TTM)

RNTX-$0.74

TENX-$1.28

ROE (TTM)

RNTX-15323.0%

TENX-6155.0%

ROA (TTM)

RNTX-11700.0%

TENX-5742.0%

ROIC (TTM)

RNTX-14763.0%

TENX-6155.0%

Cash

RNTX$9M

TENX$118M

Debt

RNTX$0

TENX$0

Net Cash/Debt

RNTX$9M

TENX$118M

Current Ratio (TTM)

RNTX4.27x

TENX15.07x

Quick Ratio (TTM)

RNTX4.26x

TENX14.65x

Debt/Equity (TTM)

RNTX0.00x

TENX0.00x

Debt/Assets (TTM)

RNTX0.0%

TENX0.0%

Interest Coverage (TTM)

RNTXN/A

TENXN/A

Net Debt/EBITDA (TTM)

RNTX0.00x

TENX0.00x

Beta

RNTX1.40

TENX1.00

52W Performance

RNTX-42.9%

TENX-76.1%

YTD Performance

RNTX-36.5%

TENX-83.1%

% from 52W High

RNTX-63.6%

TENX-90.4%

% from 52W Low

RNTX14.4%

TENX42.7%

Asset Turnover (TTM)

RNTX0.00x

TENX0.00x

FCF Yield (TTM)

RNTX-27.7%

TENX-92.8%

Earnings Yield (TTM)

RNTX-73.3%

TENX-130.7%

Dividend Yield (TTM)

RNTXN/A

TENXN/A

Rule of 40

RNTX0.0

TENX-82.9

EV/GP/RG

RNTXN/A

TENXN/A

Ticker research

View RNTX research View TENX research

Metric	RNTX Rein Therapeutics Inc	TENX Tenax Therapeutics Inc
Market & Valuation
Market Cap	$68M	$50M
Enterprise Value	$59M	$-68M
Price	$0.79	$1.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,503.03x
EV/Sales	0.00x	-889.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.25x	0.65x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.15x	1.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-82.9%
Forward Rev Growth	113.7%	111.9%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-50M	$-65M
FCF (TTM)	$-19M	$-46M
EPS (TTM)	-$0.74	-$1.28
ROE (TTM)	-15323.0%	-6155.0%
ROA (TTM)	-11700.0%	-5742.0%
ROIC (TTM)	-14763.0%	-6155.0%
Financial Health
Cash	$9M	$118M
Debt	$0	$0
Net Cash/Debt	$9M	$118M
Current Ratio (TTM)	4.27x	15.07x
Quick Ratio (TTM)	4.26x	14.65x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	1.00
52W Performance	-42.9%	-76.1%
YTD Performance	-36.5%	-83.1%
% from 52W High	-63.6%	-90.4%
% from 52W Low	14.4%	42.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-27.7%	-92.8%
Earnings Yield (TTM)	-73.3%	-130.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-82.9
EV/GP/RG	N/A	N/A
Ticker research	View RNTX research	View TENX research